Dishman Carbogen Amcis Limited

Yield per half year: -7.13%
Dividend yield: 0%
Sector: Healthcare

Dishman Carbogen Amcis Limited

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
1/10
1209.72 154.04 685.34% 348.78 +246.84%
P/S 1.48 16.8 -91.17%
P/BV 0.6721 5.28 -87.27%
P/FCF 24.73 -126.4 -119.57%
Ev/Ebitda 11.59 7.77 49.24%
Ev/S 1.97 8.8 -77.61%
Ev/FCF 32.86 -189.44 -117.35%
E/P 0.000827 0.0219 -96.22%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
4/10
11.8 -21.41 -155.11% 13.46 -12.28%
ROE 0.0556 11.42 -99.51%
ROA 0.0324 3.58 -99.09%
ROIC 0 10.03 -100%
ROS 0.1226 -44.41 -100.28%
ROCE 2.6 6.84 -62%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
0/10
6.68 0.2425 2653.52% 130.67 -94.89%
Nеt Debt/Ebitda 5.76 0.1911 2914.56%
Debt/Ratio 0.2082 0.1294 60.9%
Debt/Equity 0.7147 0.5324 34.23%
Debt/Net Income 642.51 43.4 1380.5%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.394 -100% 0.4728 -100%
Number of years of dividend growth 0 0.8269 -100%
DSI 0.7857 0.8258 -4.85%
Average dividend growth -32.22 -26.14 23.29%
Average percentage for 5 years 0.4728 0.7649 -38.18%
Average percentage for payments 4.68 20.21 -76.82%
Difference from average difference in sector -0.394

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
5/10
38.18 75.03 -49.11%
Growth impulse Ebitda in 5 years -47.25 55.38 -185.32%
Growth impulse Net Income in 5 years -101.96 132.06 -177.21%
Growth impulse FCF in 5 years 7.51 63.56 -88.18%
Growth impulse EPS in 5 years -101.96 9.17 -1211.89%
IP Score
2.97/10

Similar companies

Sequent Scientific Limited

Wockhardt Limited

Shilpa Medicare Limited

IOL Chemicals and Pharmaceuticals Limited

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription